Cargando…

Validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial

OBJECTIVE: To determine if a targeted and tailored intervention based on a discussion informed by validated adherence scales will improve medication adherence. DESIGN: Prospective randomised trial. SETTING: 2 community pharmacies in Brisbane, Australia. METHODS: Patients recently initiated on a card...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thi-My-Uyen, La Caze, Adam, Cottrell, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168495/
https://www.ncbi.nlm.nih.gov/pubmed/27903564
http://dx.doi.org/10.1136/bmjopen-2016-013375
_version_ 1782483354594050048
author Nguyen, Thi-My-Uyen
La Caze, Adam
Cottrell, Neil
author_facet Nguyen, Thi-My-Uyen
La Caze, Adam
Cottrell, Neil
author_sort Nguyen, Thi-My-Uyen
collection PubMed
description OBJECTIVE: To determine if a targeted and tailored intervention based on a discussion informed by validated adherence scales will improve medication adherence. DESIGN: Prospective randomised trial. SETTING: 2 community pharmacies in Brisbane, Australia. METHODS: Patients recently initiated on a cardiovascular or oral hypoglycaemic medication within the past 4–12 weeks were recruited from two community pharmacies. Participants identified as non-adherent using the Medication Adherence Questionnaire (MAQ) were randomised into the intervention or control group. The intervention group received a tailored intervention based on a discussion informed by responses to the MAQ, Beliefs about Medicines Questionnaire-Specific and Brief Illness Perception Questionnaire. Adherence was measured using the MAQ at 3 and 6 months following the intervention. RESULTS: A total of 408 patients were assessed for eligibility, from which 152 participants were enrolled into the study. 120 participants were identified as non-adherent using the MAQ and randomised to the ‘intervention’ or ‘control’ group. The mean MAQ score at baseline in the intervention and control were similar (1.58: 95% CI (1.38 to 1.78) and 1.60: 95% CI (1.43 to 1.77), respectively). There was a statistically significant improvement in adherence in the intervention group compared to control at 3 months (mean MAQ score 0.42: 95% CI (0.27 to 0.57) vs 1.58: 95% CI (1.42 to 1.75); p<0.001). The significant improvement in MAQ score in the intervention group compared to control was sustained at 6 months (0.48: 95% CI (0.31 to 0.65) vs 1.48: 95% CI (1.27 to 1.69); p<0.001). CONCLUSIONS: An intervention that targeted non-adherent participants and tailored to participant-specific reasons for non-adherence was successful at improving medication adherence. TRIAL REGISTRATION NUMBER: ACTRN12613000162718; Results.
format Online
Article
Text
id pubmed-5168495
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51684952016-12-22 Validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial Nguyen, Thi-My-Uyen La Caze, Adam Cottrell, Neil BMJ Open Health Services Research OBJECTIVE: To determine if a targeted and tailored intervention based on a discussion informed by validated adherence scales will improve medication adherence. DESIGN: Prospective randomised trial. SETTING: 2 community pharmacies in Brisbane, Australia. METHODS: Patients recently initiated on a cardiovascular or oral hypoglycaemic medication within the past 4–12 weeks were recruited from two community pharmacies. Participants identified as non-adherent using the Medication Adherence Questionnaire (MAQ) were randomised into the intervention or control group. The intervention group received a tailored intervention based on a discussion informed by responses to the MAQ, Beliefs about Medicines Questionnaire-Specific and Brief Illness Perception Questionnaire. Adherence was measured using the MAQ at 3 and 6 months following the intervention. RESULTS: A total of 408 patients were assessed for eligibility, from which 152 participants were enrolled into the study. 120 participants were identified as non-adherent using the MAQ and randomised to the ‘intervention’ or ‘control’ group. The mean MAQ score at baseline in the intervention and control were similar (1.58: 95% CI (1.38 to 1.78) and 1.60: 95% CI (1.43 to 1.77), respectively). There was a statistically significant improvement in adherence in the intervention group compared to control at 3 months (mean MAQ score 0.42: 95% CI (0.27 to 0.57) vs 1.58: 95% CI (1.42 to 1.75); p<0.001). The significant improvement in MAQ score in the intervention group compared to control was sustained at 6 months (0.48: 95% CI (0.31 to 0.65) vs 1.48: 95% CI (1.27 to 1.69); p<0.001). CONCLUSIONS: An intervention that targeted non-adherent participants and tailored to participant-specific reasons for non-adherence was successful at improving medication adherence. TRIAL REGISTRATION NUMBER: ACTRN12613000162718; Results. BMJ Publishing Group 2016-11-30 /pmc/articles/PMC5168495/ /pubmed/27903564 http://dx.doi.org/10.1136/bmjopen-2016-013375 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Health Services Research
Nguyen, Thi-My-Uyen
La Caze, Adam
Cottrell, Neil
Validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial
title Validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial
title_full Validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial
title_fullStr Validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial
title_full_unstemmed Validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial
title_short Validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial
title_sort validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial
topic Health Services Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168495/
https://www.ncbi.nlm.nih.gov/pubmed/27903564
http://dx.doi.org/10.1136/bmjopen-2016-013375
work_keys_str_mv AT nguyenthimyuyen validatedadherencescalesusedinameasurementguidedmedicationmanagementapproachtotargetandtailoramedicationadherenceinterventionarandomisedcontrolledtrial
AT lacazeadam validatedadherencescalesusedinameasurementguidedmedicationmanagementapproachtotargetandtailoramedicationadherenceinterventionarandomisedcontrolledtrial
AT cottrellneil validatedadherencescalesusedinameasurementguidedmedicationmanagementapproachtotargetandtailoramedicationadherenceinterventionarandomisedcontrolledtrial